Our publications in the journals PLOS One and Cancer Control

Scientists at HYD LLC for Cancer Research and Drug Development contributed to the development of this research field with two scientific papers containing their latest results. In the paper published on 8 April 2021 in the journal PLOS One, results of investigating the effect of presence of deuterium (D) on mutation frequency of cells were presented. The results showed 0.663-fold decrease of mutation rate in three different Escherichia coli strains under low D (2 ppm) conditions. The conclusion of the paper is that presence of D has no deterministic effect on mutation frequency but may influence the probability of mutations to occur.

The paper published on 24 March 2021 in Cancer Control summarizes the results related to the effect of deuterium depletion on pancreatic tumors. The published results showed that deuterium depleted water dose-dependently inhibited the growth of cultured MIA PaCa-2 pancreatic tumor cell line in vitro and increased the expectable median survival time of pancreatic tumor patients severalfold in a human retrospective clinical study.

The press release of HYD LLC in B3C Newswire was shared by Wallstreet Online, Financial Times, and several other news channels.

• https://www.b3cnewswire.com/202003132051/deuterium-depletion-as-a-possible-new-strategy-to-combat-sars-cov-2.html
• https://www.wallstreet-online.de/nachricht/13691301-dgap-news-hyd-llc-for-cancer-research-and-drug-development-hyd-substantiates-the-science-of-deuterium-s-role-cancer-with-two-new-peer-reviewed-articles
• https://markets.ft.com/data/announce/detail?dockey=600-202103251100DGAP____CORPNEWS_corporate_1178572_en-1

2021 March 31. Wednesday